Seven patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Apr 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Apr 2027
Next term end
6
Patent families
When these terms end
Each bar runs from grant to computed term end. 2011 to 2042.
US 10,059,683
Process for the Production of Cannabidiol and DELTA-9-Tetrahydrocannabinol
Jun 30, 2036
US 10,844,035
Process for the Production of Cannabidiol and DELTA-9-Tetrahydrocannabinol
Jun 30, 2036
US 12,269,810
Methods of Preparing Synthetic Cannabichromene and Cannabicitran and Derivatives Thereof
Jul 17, 2041
201720232029203520412042
4 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2036 · High confidence
Also notable
Ends Apr 2027 · High confidence
Also notable
Ends Feb 2041 · High confidence
Process for the Production of Cannabidiol and DELTA-9-Tetrahydrocannabinol
US 10,059,683
The most cited patent in this portfolio, cited by 35 later US patents, top 10% of utility patents granted in 2018 in our data. Protection runs to 2036.
Method for Obtaining Pure Tetrahydrocannabinol
US 7,923,558
Renewed at every maintenance window since the 2011 grant; no more fees are due before its term ends in 2027.
Cannabidiol Compositions Having Modified Cannabinoid Profiles
US 12,144,795
Granted 2024. Too new for citation comparison; protection runs to 2041.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 10, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Process for the Production of Cannabidiol and DELTA-9-Tetrahydrocannabinol | 2 in force | to Jun 2036 |
| Methods of Preparing Synthetic Cannabinol and Homologs Thereof | 1 in force | to Aug 2042 |
| Methods of Preparing Synthetic Cannabichromene and Cannabicitran and Derivatives Thereof | 1 in force | to Jul 2041 |
| Polymorphs of D9-THC Naphthoylester | 1 in force | to Jul 2041 |
| Cannabidiol Compositions Having Modified Cannabinoid Profiles | 1 in force | to Feb 2041 |
Patents held now
Soonest term end first.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,923,558 | Method for Obtaining Pure Tetrahydrocannabinol In force · High confidence | In force | High confidence | |
| US 10,059,683 | Process for the Production of Cannabidiol and DELTA-9-Tetrahydrocannabinol In force · High confidence | In force | High confidence | |
| US 10,844,035 | Process for the Production of Cannabidiol and DELTA-9-Tetrahydrocannabinol In force · High confidence | In force | High confidence | |
| US 12,144,795 | Cannabidiol Compositions Having Modified Cannabinoid Profiles In force · High confidence | In force | High confidence | |
| US 12,522,576 | Polymorphs of D9-THC Naphthoylester In force · High confidence | In force | High confidence | |
| US 12,269,810 | Methods of Preparing Synthetic Cannabichromene and Cannabicitran and Derivatives Thereof In force · High confidence | In force | High confidence | |
| US 12,338,223 | Methods of Preparing Synthetic Cannabinol and Homologs Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 7: 4 applications pending · 1 application abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.